Patents Assigned to HARMONIGENIC CORPORATION
  • Methods and systems for treating cancer based on response prediction using light scattering technology
    Patent number: 12211618
    Abstract: Disclosed are methods and systems that make use of light scattering techniques, such as the use of a multiphoton laser-scanning microscope, to quantify the scattering directionality of second harmonic generation (SHG) from biopsy samples of cancer in order to predict efficacy of neoadjuvant chemotherapy.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: January 28, 2025
    Assignees: THE UNIVERSITY OF ROCHESTER, HARMONIGENIC CORPORATION
    Inventors: Robert Lawrence Hill, Edward Bernard Brown, David Hicks, Brandon Buscaglia, Bradley Turner, Danielle Desa